CRISPR Therapeutics AG

time to get back to CRSP

331
Price is at 50% retrace from Nov 3rd at around 86$. major support at the current price level.

I believe it is still ARKG's top holding at the moment with lots of the biotech took a hit since beginning of the year.

This might be a golden opportunity to get back into the CRSP/EDIT/NTLA stocks. I am starting adding to my positions.


Disclaimer, this is only for entertainment and education purposes and doesn't serve by any means as a buy or sell recommendation.
Personally I hold both long term long positions and occasionally short term short position, for disclosure purpose.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。